Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

flibanserin Oral Tablet [Addyi]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
In 2015, the drug Addyi® (flibanserin) was launched, the first drug to treatment of Female Sexual Interest/Arousal Disorder… 
Review
2015
Review
2015
How a woman responds to sexual cues is highly dependent on a number of distinct, yet related, factors. Researchers have attempted… 
  • figure 1
  • figure 2
  • figure 3
  • table 1
Review
2015
Review
2015
Flibanserin (Addyi™) is chemically described as a benzimidazole and is being developed by Sprout Pharmaceuticals for the…